Answer
It is contraindicated during suspected or actively treated breast cancer. After treatment has finished, use requires an individual specialist assessment because evidence in people with previous breast cancer is limited.
Sources for this answer
- Senshio 60 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 5